141 related articles for article (PubMed ID: 32341236)
1. Aberrant Expression of E-cadherin, N-cadherin, and P-cadherin in Clear Cell Renal Cell Carcinoma: Association With Adverse Clinicopathologic Factors and Poor Prognosis.
Jang NR; Choi JH; Gu MJ
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):223-230. PubMed ID: 32341236
[TBL] [Abstract][Full Text] [Related]
2. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
[TBL] [Abstract][Full Text] [Related]
3. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
6. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer.
Yang FQ; Yang FP; Li W; Liu M; Wang GC; Che JP; Huang JH; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):110-22. PubMed ID: 24427331
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
[TBL] [Abstract][Full Text] [Related]
8. Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma.
Liu Q; Rexiati M; Yang Y; Wang WG; Azhati B; Saimaiti W; Wang YJ
Med Oncol; 2014 Apr; 31(4):882. PubMed ID: 24554520
[TBL] [Abstract][Full Text] [Related]
9. Expression of Neural Wiskott-Aldrich Syndrome Protein in Clear Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features.
Liu GH; Chen J; Ji ZG; Zhou L
Urol Int; 2015; 95(1):79-85. PubMed ID: 25115631
[TBL] [Abstract][Full Text] [Related]
10. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
[TBL] [Abstract][Full Text] [Related]
11. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
12. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
Shimazui T; Kojima T; Onozawa M; Suzuki M; Asano T; Akaza H
Oncol Rep; 2006 May; 15(5):1181-4. PubMed ID: 16596183
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma.
Chang Y; Xu L; Zhou L; Fu Q; Liu Z; Yang Y; Lin Z; Xu J
Oncotarget; 2016 Apr; 7(17):24527-36. PubMed ID: 27016418
[TBL] [Abstract][Full Text] [Related]
15. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
17. Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.
Qu Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Xiong Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Dec; 7(51):84775-84784. PubMed ID: 27713173
[TBL] [Abstract][Full Text] [Related]
18. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
Oz Atalay F; Aytac Vuruskan B; Vuruskan H
APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma.
Gasinska A; Jaszczynski J; Adamczyk A; Janecka-Widła A; Wilk W; Cichocka A; Stelmach A
Folia Histochem Cytobiol; 2018; 56(4):195-206. PubMed ID: 30569446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
